Us Bancorp »

Bioxcel Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2023-12-31 $53k 18k 2.95
2023-09-30 $46k 18k 2.53
2023-06-30 $94k 14k 6.66
2023-03-31 $616 33 18.67
2022-12-31 $708 33 21.48
2022-09-30 $5.0k 415 12.05
2022-06-30 $8.0k 611 13.09
2022-03-31 $15k 717 20.92
2021-12-31 $17k 827 20.56
2021-09-30 $32k 1.1k 30.48
2021-06-30 $41k 1.4k 29.33
2021-03-31 $212k 4.9k 43.17
2020-12-31 $238k 5.2k 46.18
2020-09-30 $207k 4.8k 43.27
2020-06-30 $124k 2.3k 52.95
2020-03-31 $68k 3.0k 22.38